• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Kara Trott, founder and CEO, Quantum Health, Inc.

Article

As founder and CEO of Quantum Health, Kara Trott has left a mark on disease management with a program called Coordinated Health/Care.

Kara Trott
Founder and CEO
Quantum Health, Inc.

Without any plan design changes or benefit changes, the company has reduced days of care, ER visits and specialist visits across its entire population, while primary care visits have correspondingly increased. Its employers as a group have held overall trend under 5% this decade, as validated by DMPC and independent actuaries.

Trott began her career in consumer behavior and strategic planning, working as a consultant for such companies as Citibank, Ford and Kmart. She was the recipient of the Ernst & Young regional "Entrepreneur of the Year" award in 2005

Related Content
© 2024 MJH Life Sciences

All rights reserved.